Acceleron Pharma to Present at Two Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced it will give corporate presentations at two upcoming investor conferences. John Knopf, Ph.D., Chief Executive Officer, will provide a corporate presentation at the Piper Jaffray 23rd Annual Health Care Conference and Steven Ertel, Senior Vice President, Corporate Development, will present at the Oppenheimer 22nd Annual Healthcare Conference. The details for each presentation are shown below.